Old Web
English
Sign In
Acemap
>
authorDetail
>
Thomas D. Garvey
Thomas D. Garvey
Mayo Clinic
Medicine
Apicidin
Histone deacetylase inhibitor
Trichostatin A
Histone H4
5
Papers
56
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Incidence, survival, and diagnostic trends in GCA across seven decades in a North American population-based cohort
2021
Seminars in Arthritis and Rheumatism
Thomas D. Garvey
Matthew J. Koster
Cynthia S. Crowson
Kenneth J. Warrington
Show All
Source
Cite
Save
Citations (0)
My Treatment Approach to Giant Cell Arteritis.
2021
Thomas D. Garvey
Matthew J. Koster
Kenneth J. Warrington
Show All
Source
Cite
Save
Citations (0)
Long-Term Rituximab Use to Maintain Remission of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
2020
Annals of Internal Medicine
Thomas D. Garvey
Kenneth J. Warrington
Matthew J. Koster
Show All
Source
Cite
Save
Citations (0)
Development of biopsy-proven giant cell arteritis in a patient with dermatomyositis on methotrexate: comment on the article by Monti et al.
2020
Clinical and Experimental Rheumatology
Thomas D. Garvey
Clement J. Michet
Linda N. Dao
Matthew J. Koster
Show All
Source
Cite
Save
Citations (0)
SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma.
2006
Gastroenterology
Jin Ping Lai
Chunrong Yu
Catherine D. Moser
Ileana Aderca
Tao Han
Thomas D. Garvey
Linda M. Murphy
Megan M. Garrity-Park
Viji Shridhar
Alex A. Adjei
Lewis Rowland Roberts
Show All
Source
Cite
Save
Citations (56)
1